GenScript ProBio announced that it has received $220,000,000 in its Series C round of funding led by Legend Capital Management Co., Ltd. on January 18, 2023. The transaction included participation from HighLight Capital, GF Xinde Investment Management Co., Ltd, GL Ventures, Xiamen C&D Inc., Shanghai New Alliance Investment Management Co., Ltd., Huatai Zijin Investment Co. Ltd and China Industrial International Trust Asset Management Limited.